Results 321 to 330 of about 115,534 (346)
Genotoxicity of Nanoparticles [PDF]
As previously mentioned, the genotoxic properties of nanomaterials (NMs) are often closely linked to oxidative damage to DNA and proteins caused by oxidative stress resulting from hyper production of reactive oxygen species (ROS) and reactive nitrogen species (RNS).
Laila Benameur, Fabrice Nesslany
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Molecular Aspects of Medicine, 2003
Since previous investigations on the genotoxicity of 4-hydroxynonenal (HNE) were carried out with prokaryotic systems or eukaryotic cell lines which may not adequately reflect the response of cells in vivo due to differences in the metabolism, the genotoxic potential of HNE was further evaluated in primary cells (hepatocytes) and cell clones of ...
openaire +2 more sources
Since previous investigations on the genotoxicity of 4-hydroxynonenal (HNE) were carried out with prokaryotic systems or eukaryotic cell lines which may not adequately reflect the response of cells in vivo due to differences in the metabolism, the genotoxic potential of HNE was further evaluated in primary cells (hepatocytes) and cell clones of ...
openaire +2 more sources
Mutation Research/Reviews in Genetic Toxicology, 1985
Selenium at nutritional levels has been shown to have numerous anticarcinogenic or preventative effects against carcinogen-induced breast, colon, liver and skin cancer in animals. Many of these anticarcinogenic effects have been summarized. In addition, numerous mutagenic and antimutagenic effects of selenium compounds have been reported.
openaire +3 more sources
Selenium at nutritional levels has been shown to have numerous anticarcinogenic or preventative effects against carcinogen-induced breast, colon, liver and skin cancer in animals. Many of these anticarcinogenic effects have been summarized. In addition, numerous mutagenic and antimutagenic effects of selenium compounds have been reported.
openaire +3 more sources
Overview of genotoxic carcinogens and non-genotoxic carcinogens
Experimental and Toxicologic Pathology, 1992It is known that carcinogens designated on the basis of longterm animal test results are extremely diverse in character, both in terms of potencies and the mechanism of action, which leads to complexity in their assessment for cancer risk to humans. The classification of carcin0ogens into two categories, namely, genotoxic and non-genotoxic varieties ...
openaire +3 more sources
Genotoxicity of nitrosated ranitidine
Mutation Research Letters, 1989The genotoxicity of ranitidine, widely used in the therapy of peptic ulcers, and of nitrosated ranitidine was examined in test systems with the bacteria Salmonella typhimurium for gene mutations, and with the yeast Saccharomyces cerevisiae D7 for reverse mutations and gene conversion.
Zdenka Matijasevic+2 more
openaire +5 more sources
Genotoxicity of dithiocarbamates and their metabolites
Mutation Research Letters, 1994Dithiocarbamate fungicides are widely used in agriculture for protection of vegetable crops and seeds. The mutagenicity spectra of ziram, thiram, zineb S-65 and ETU were determined by employing a battery of test systems included the bacterium Salmonella typhimurium (strains TA98, TA100, TA102, TA104, TA1535, TA1538), the yeast Saccharomyces cerevisiae (
N. Bratulić+3 more
openaire +4 more sources
Genotoxicity of monosodium glutamate
Food and Chemical Toxicology, 2016Monosodium glutamate (MSG) is one of the most widely used flavor enhancers throughout the world. The aim of this study is to investigate the genotoxic potential of MSG by using chromosome aberrations (CAs), sister-chromatid exchanges (SCEs), cytokinesis-blocked micronucleus (CBMN), and random amplified polymorphic DNA-polimerase chain reaction (RAPD ...
Ataseven, Nazmiye+3 more
openaire +4 more sources
2021
The assessment of the potential of a new drug to cause genotoxicity is a prerequisite for its progression to clinical development. This chapter gives a concise overview of the major aspects relating to genotoxicity, which are relevant in small molecule drug discovery. Testing schemes and assays recommended by regulatory guidelines are outlined.
Stephan Kirchner, Patrick Schnider
openaire +2 more sources
The assessment of the potential of a new drug to cause genotoxicity is a prerequisite for its progression to clinical development. This chapter gives a concise overview of the major aspects relating to genotoxicity, which are relevant in small molecule drug discovery. Testing schemes and assays recommended by regulatory guidelines are outlined.
Stephan Kirchner, Patrick Schnider
openaire +2 more sources
Indirect mechanisms of genotoxicity
Toxicology Letters, 2003Indirect mechanisms of genotoxicity correspond to interactions of mutagens with non-DNA targets, and are expected to show threshold concentration-effect response curves. If these thresholds can be proven experimentally they may provide a third alternative for risk assessment, besides the No Effect Level/Safety Factor approach and the low dose linear ...
Volders, Micheline+3 more
openaire +4 more sources
2003
Bacterial mutagenesis assays have been used as preliminary screens for the evaluation of chemicals because they are rapid, simple, and are correlated with carcinogeneity in humans (1). The activation of bacterial DNA repair systems (recently reviewed; 2,3) can be used as a measure of mutagenic and genotoxic effects of various chemical as well as ...
openaire +3 more sources
Bacterial mutagenesis assays have been used as preliminary screens for the evaluation of chemicals because they are rapid, simple, and are correlated with carcinogeneity in humans (1). The activation of bacterial DNA repair systems (recently reviewed; 2,3) can be used as a measure of mutagenic and genotoxic effects of various chemical as well as ...
openaire +3 more sources